Nuvation Bio (NUVB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Post Holdings (POST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

It doesn't matter if you're a growth, value, income, or momentum-focused investor -- building a successful investment portfolio takes skill, research, and a little bit of luck. But what's the best way ...

(BSET) on Wednesday reported fiscal second-quarter net income of $1.9 million, after reporting a loss in the same ...

CHICAGO (AP) — CHICAGO (AP) — Methode Electronics Inc. (MEI) on Wednesday reported a loss of $28.3 million in its fiscal fourth quarter. The Chicago-based company said it had a loss of 80 cents per ...

Note: The following is an excerpt from this week’s Earnings Trends report. You can access the full report that contains ...

Theratechnologies Inc. (THTX) on Wednesday reported a loss of $4.5 million in its fiscal second quarter. The Montreal-based company said it had a loss of 9 cents ...

The June increase came as Tesla reduced exports from its Giga Shanghai plant. It exported 10,115 vehicles, down 56.2% from ...

Sovereign AI refers to countries building their own national AI infrastructure, using trusted platforms to protect data, ...

Brian Mulberry, client portfolio manager with Zacks Investment Management, says NVIDIA reaching a $4 trillion market cap is ...